Skip to main content
bioMérieux logo

bioMérieux — Investor Relations & Filings

Ticker · BIM ISIN · FR0013280286 LEI · 549300AK8Y0LBIQ4T071 PA Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2019-11-17 Transaction in Own Shar…
Country FR France
Listing PA BIM

About bioMérieux

https://www.biomerieux.com/

bioMérieux is a global leader in the field of in vitro diagnostics, providing solutions that determine the source of disease and contamination. The company develops and manufactures diagnostic systems, reagents, and software for both clinical and industrial applications. In the clinical sector, its products are used for diagnosing infectious diseases, managing sepsis, combating antimicrobial resistance, and supporting cancer screening and cardiovascular emergencies. For industrial markets, bioMérieux offers microbiological control solutions to ensure the safety and quality of agri-food, pharmaceutical, and cosmetic products. These technologies provide rapid and reliable data to help healthcare professionals and industrial quality control managers make critical decisions that improve patient outcomes and ensure consumer safety.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Transaction in Own Shares Classification · 100% confidence The document is titled "Information Réglementée – déclaration de transactions sur actions propres" (Regulated Information - declaration of transactions on own shares) and explicitly states it is reporting transactions realized on its own shares ("transactions réalisées sur ses actions propres") for a specific period (November 8 to 14, 2019), referencing EU Market Abuse Regulation (MAR). This content directly corresponds to the definition of reporting the company buying back or selling its own shares. The filing type code 'POS' (Transaction in Own Shares) is the most appropriate classification.
2019-11-17 French
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Informations mensuelles relatives au nombre total de droits de vote et d'actions prévues par l'article L. 233-8 II du code de commerce et l'article 223-16 du règlement général de l'Autorité des marchés financiers". This explicitly indicates a monthly disclosure regarding the total number of voting rights and shares, as required by French commercial code and AMF regulations. This type of filing, which reports on share capital structure and voting rights, most closely aligns with the definition of a Major Shareholding Notification (MRQ) or a general regulatory filing. Given the specific nature of reporting total voting rights monthly, it is a recurring regulatory disclosure. While MRQ usually refers to changes in significant ownership, this document reports the total count, which is often grouped with share/capital structure updates. However, since it is a mandatory monthly disclosure of the total share count and voting rights, it fits best under the general category for mandatory regulatory updates that aren't specifically 10-K, ER, or DIV. In the provided list, 'Major Shareholding Notification' (MRQ) is the closest fit for disclosures related to share counts and voting rights, even if it's a total count rather than a change notification. Alternatively, it could be RNS, but MRQ is more specific to share structure reporting.
2019-11-08 French
Quarterly financial reporting / Third quarter financial report
Interim / Quarterly Report Classification · 100% confidence The document is a 'Third-Quarter 2019 Business Review' from bioMérieux. It provides detailed financial data, including sales figures, organic growth analysis, and regional performance breakdowns for the nine-month period ending September 30, 2019. It contains substantive financial tables and management commentary on business trends. Since it covers a period shorter than a full fiscal year and includes actual financial statements/data, it is classified as an Interim/Quarterly Report. 9M 2019
2019-10-22 English
Information financière trimestrielle / Information financière du troisième trimestre
Interim / Quarterly Report Classification · 100% confidence The document is a quarterly financial update from bioMérieux for the third quarter of 2019. It provides detailed financial data, including revenue growth, regional performance, and business segment analysis, as well as forward-looking guidance. It is not a full annual report (10-K) nor a simple announcement of a report (RPA), as it contains substantive financial tables and analysis. It fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data for a period shorter than a full fiscal year. 9M 2019
2019-10-22 French
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 95% confidence The document is titled "Informations mensuelles relatives au nombre total de droits de vote et d'actions prévues par l'article L. 233-8 II du code de commerce et l'article 223-16 du règlement général de l'Autorité des marchés financiers". This explicitly refers to the mandatory monthly disclosure of the total number of voting rights and shares, as required by French financial regulations (AMF). This type of filing, which reports on share capital structure and voting rights as of a specific date (here, 31/08/2019), is a standard regulatory disclosure. While it is a specific type of regulatory filing, none of the provided codes perfectly match 'Monthly Voting Rights Disclosure'. However, it is a formal regulatory announcement. Given the options, it is closest to a general Regulatory Filing (RNS) or potentially a Share Issue/Capital Change (SHA) if it were about a change, but since it's a routine monthly update on existing structure, RNS is the most appropriate general regulatory category, as it doesn't fit the specific definitions like 10-K, ER, or DIV. It is not a DVA (Declaration of Voting Results) as that refers to the outcome of a shareholder meeting vote, not the monthly count.
2019-09-05 French
Rapports financiers et d'audit semestriels/examens réduits / Modalités de mise à disposition du rapport financier semestriel
Report Publication Announcement Classification · 99% confidence The document is titled "Avis de mise à disposition du rapport financier semestriel 2019" (Notice of availability of the 2019 semi-annual financial report). It explicitly states that the semi-annual financial report for the period ending June 30, 2019, has been made available to the public and transmitted to the AMF (Autorité des marchés financiers). The document itself is very short (675 characters) and serves only to announce that the actual report is available online. This perfectly matches the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports.
2019-09-05 French

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.